MFS
ABUS icon

Mirabella Financial Services’s Arbutus Biopharma ABUS Stock Holding History

Mirabella Financial Services’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-40,280
Closed -$143K – 263
2020
Q4 		$143K Sell
40,280
-12,612
-24% -$44.2K 0.02% 268
2020
Q3 		$166K Buy
+52,892
New +$161K 0.02% 296

Other funds holding ABUS

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mirabella Financial Services's ABUS Position: Q1 2021 in Review

Mirabella Financial Services sold out of Arbutus Biopharma (ABUS) in Q1 2021, closing a stake of 40,280 shares — an estimated $143K sold.

Mirabella Financial Services first reported a position in ABUS in Q3 2020 and held it in 2 quarters. The position peaked at $166K in Q3 2020. 94 funds tracked by Wall St. Rank hold ABUS as of Q1 2021.

  • Mirabella Financial Services reported no remaining Arbutus Biopharma position as of Q1 2021 after selling out during the quarter.
  • Mirabella Financial Services sold 40,280 Arbutus Biopharma shares in Q1 2021, an estimated $143K.
  • Mirabella Financial Services first reported a position in Arbutus Biopharma in Q3 2020 and held it in 2 quarters.
  • Mirabella Financial Services's Arbutus Biopharma position peaked at $166K in Q3 2020.
  • 94 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2021.

Based on Mirabella Financial Services's 13F filing for Q1 2021, filed 17 May 2021.